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ABSTRACT 
Meningioma is a common intracranial neoplasm derived from meningothelial cells, 
and it is generally associated with a benign clinical course. In spite of this, the 
malignant behaviour of these tumours as the occurrence of extracranial meningioma 
metastases in different organs is described in literature: lung and pleura, spine and 
other bones, abdominal organs, lymph nodes or even skin. The aim of this review is 
to analyse the pathways of metastatic spread of the intracranial meningioma tumour 
cells towards different organs. 
 
 
INTRODUCTION  
Meningiomas are the most common central nervous system tumours 
in adults, making up approximately 30% of all the intracranial tumours, 
with an increasing incidence (14, 57). According to the mitotic activity 
and tumour differentiation, the World Health Organization (WHO) 
grading meningiomas as it follows: grade I, grade II and grade III, the 
last two being characterized by a more aggressive behaviour, a high risk 
of recurrence (12, 39) and even metastasis. These extracranial 
meningioma metastases (EMM) are more frequently associated with 
atypical meningiomas (Table 1) or anaplastic meningiomas (20, 27, 59). 
Although typical meningiomas are benign solitary intracranial 
neoplasms, they can cause extracranial metastasis, a rare phe-
nomenon found only in 0.1% of cases (15, 23, 26, 35, 37). According to 
epidemiological data, about one in 1000 cases of meningiomas 
metastasize (35, 56).  
 The most frequent sites of EMM are: the lung (60%-70%), abdominal 
viscera (the liver most frequently) (30-40%), pleura (23%), lymph nodes 
(14-20%) and bones (10%) (3, 6, 21, 38, 42, 50, 60, 66). Other rare 
localizations were identified in the parotid gland (17), skin (32, 51), deep 
soft tissue (9, 18, 44, 48, 64, 70), kidney, spleen, thyroid and adrenal 
gland (64). 
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Due to the rare nature of EMM, this is a challenging 
diagnosis for physicians and pathologists (25). 
Because the treatment has not yet been standard-
ized and a management protocol has not been 
developed, the prognosis of these patients remains 
unknown (3, 42, 50). 
 
TABLE 1. Review of publications on extracranial metastasis of atypical meningiomas 
 
METASTATIC SPREAD 
Although all types of meningioma, including the 
grade I meningiomas can metastasize, EMM is more 
common in the atypical (5%) and anaplastic (30%) 
histopathological subtypes (7). Nevertheless, some 
authors believe that these percentages are 
overestimated, firstly because some of the reported 
cases probably are metastatic angioblastic 
meningiomas and not genuine meningioma 
metastases. Moreover, the angioblastic meningioma 
is now classified as haemangiopericytoma (25, 28, 
34, 46). Thus, considering all these modifications, the 
5% rate of metastasis in atypical meningiomas does 
not coincide with the current WHO classification (25). 
However, the true prevalence of EMM is unknown at 
present (64).As for the time interval between the 
initial diagnosis of the meningioma and that of 
extracranial metastasis, it varies from 3 months to 30 
years (40). 
 Although throughout time, some authors 
emphasized tumour necrosis, blood vessel invasion, 
high cellularity, cellular heterogeneity, high mitosis 
rate and nuclear pleomorphism in the occurrence of 
EMM (1, 20, 54), these criteria apply to malignant 
tumours and do not explain metastatic disease in 
benign meningiomas (64). In spite of this, the exact 
etiology of metastatic spread in meningioma is still 
unknown (7, 22). 
Initially, the surgical resection was reported as one of 
the most important risk factors for iatrogenic 
metastasis of histologically aggressive meningiomas 
(2). Hence, it was hypothesised that surgery causes 
the seeding of the lymphatics and vascular channels 
(including that of the scalp), resulting in extracranial 
metastatic disease via haematogenous or lymphatic 
route (31). Besides, other studies showed that 
tumour cells can propagate with no previous surgery 
(25, 36), considering that the invasion of adjacent 
venous sinuses can lead to extracranial spread of 
meningioma, especially when there is no history of 
surgery (23). 
 Lung metastasis. As mentioned before, the lung 
is the most common site of the EMM. In these cases, 
the seeded tumour cells access dural venous sinuses 
and cranial veins, then diffuse through the azygos 
system into pulmonary circulation and then they can 
reach either the lung or the pleura (21, 32, 40). Most 
EMM were found along the jugular vascular 
drainage, such as in the cervical lymph nodes, 
parotid and thyroid gland and finally in lung and 
pleura (64). 
Bone metastasis. Bone is one of the least 
common sites of meningioma metastasis (38, 60). In 
a review of meningioma metastasis in the bone, 
Khan et al. found out that half of the patients had 
multiple areas of bone metastatic disease, while the 
Author Gender, Age Intracranial Localization Metastasis Localization 
Andric et al. (5) F 52 parasagittal lung 
Baek et al. (9) M 44 nasal septum chest wall, parietal region 
Drummond et al. (19)  M 66 frontal lung 
Doxtader et al. (18) M 8 parasagittal subcutaneous tissue of neck, 
lymph nodes 
Kim et al. (41) M 68 parietal skull bone 
Lanfranchi et al. (43)  M 74 not specified lung, liver 
Pinsker et al. (55) M 76 frontal cervical spine 
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other half had solitary bone involvement (40). The 
most common region was the axial skeleton, namely 
the thoracolumbar spine and sacrum (40), while 
metastases in the extra-axial bone were rarely 
identified (22). The most common involvement of the 
spine can be explained by the connection between 
the dural venous sinuses and the vertebral venous 
system (10). This route via the paravertebral venous 
plexus may also play a role in the metastatic spread 
across the kidney or adrenal glands (64). 
 Of the non-axial skeleton, the femur was the most 
common long bone site of involvement (40), and this 
metastasis location is more difficult to explain, even 
if some authors suggested the extension of the 
tumour via arterial spread (68). The bone metastatic 
disease is a lytic bone lesion and may result in 
pathological fractures or collapse of the vertebral 
bodies (40). 
 Liver metastasis. As far as the dissemination 
pathways for hepatic metastasis are concerned, 
some authors believe that this lies in the dissem-
ination through the vertebral venous system 
connected with the veins of the thoracoabdominal 
wall or dissemination of tumour cells of the bone 
metastasis to the liver (24, 25). The liver can be 
involved whether the metastases pass through the 
right atrium towards the inferior vena cava and 
further into the hepatic veins (64). In literature, cases 
of hepatic metastasis of meningioma via a 
ventriculoperitoneal shunt through the cere-
brospinal fluid route were cited (51). 
 Scalp metastasis. Surgical seeding of tumour cells 
in meningioma surgery is a rare entity and it usually 
involves soft tissues near the craniotomy site (8). In 
literature, 19 such cases of scalp metastasis of 
intracranial meningiomas were reported (8). 
Scalp metastasis of meningioma were firstly 
reported by Harvey Cushing, with an incidence of 
1.21% cases in a cohort of 313 patients, which results 
in 4 patients suffering from this condition. In all of 
these cases, scalp metastases were found in surgical 
scar many years after the first surgery (4, 30, 49, 69). 
Different series reported percentages of 3% in a 
cohort of 119 patients with WHO grade II and III 
meningiomas (53) and others of 1.2% (8). 
 The suggested mechanism is intraoperative 
seeding and it may apply to all histological grades of 
meningiomas. Avecillas-Chasin et al. considers that 
immunosuppression, radiation therapy, CSF fistulae 
and multiple reoperations with subsequent surgical 
wounds problems (8). Nevertheless, the reason for 
extracranial tissue invasions is still unclear. 
 Carrying out multiple interventions can be a risk 
factor for the extracranial spreading of intracranial 
tumours, in that surgical bone deteriorates the 
natural barriers for intracranial tumour dissemi-
nation, providing access to the blood vessels and 
lymphatic system (8, 63). The higher-grade 
histopathological meningioma also contributes to 
this in case of tumours which have the tendency to 
produce greater levels of vascular endothelial 
growth factor and angiogenesis, thus favouring 
vascular invasion and metastatic behaviour (29).  
 Piecemeal resection was also presented as a risk 
factor of extracranial dissemination of tumour cells 
in WHO grade III meningiomas (8). Although initially, 
it was suggested that the latency period of menin-
gioma metastasis is influenced by the histological 
grade (2), the significant variability over this la-tency 
period proved that this is not related only to the 
histological grade of meningioma (2, 16, 30, 45, 47, 
52, 61, 62, 65, 67, 69). 
 With regard to preventing the spread of tumour 
cells, some authors recommended: air-tight closure 
of dura mater, changing the gloves and surgical 
instruments for wound closure after the intracranial 
phase, replacing the bone flap and saline irrigation, 
wound abundance before the closure (4, 33). 
 Treatment strategies. The treatment for 
meningioma metastasis has yet to be set out. In spite 
of this, metastectomy seems to improve the 
prognosis, especially when the tumour is a low-grade 
meningioma. As for the chemotherapy with 
hydroxyurea, vincristine, cyclophosphamide and 
doxorubicin, this has a limited efficiency with 
progression under chemotherapy (25). Moreover, 
some immunotherapies with interferon-α and 
somatostatin analogue were tested lately, but with 
limited effects (11, 58). Nonetheless, the choice 
treatment in meningiomas remains the gross total 
resection and adjuvant radiotherapy (13). 
 
CONCLUSIONS 
Because of the fact that EMM were rarely reported, 
there are no guidelines regarding the staging or 
treatment of EMM. Metastatic spread remains a 
therapeutic challenge and the treatment must be 
multidisciplinary evaluated. In addition, this data 
highlights the fact that metastatic dissemination of 
meningiomas is possible even under conditions of 
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benign histopathological grades and thus organ 
donation should be considered.  
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